文献速递先天性心脏病外科瓣膜外科

右心室流出道管道感染性心内膜炎:同种移植物、Contegra与Melody瓣膜的登记比较

Infective endocarditis in right ventricular outflow tract conduits: a register-based comparison of homografts, Contegra grafts and Melody transcatheter valves.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

该研究在丹麦三级中心回顾性分析右心室-肺动脉管道植入后感染性心内膜炎(IE)发生率,比较同种移植物、Contegra管道和Melody经导管瓣膜。1年IE年化发生率分别为0.40%、0.97%和6.96%,5年分别为0.27%、1.12%和2.89%;以同种移植物为参照,Melody瓣膜风险显著升高(HR 11.89,95%CI 2.91-48.48,P<0.001),Contegra未达统计学显著(HR 3.20,95%CI 0.91-11.17,P=0.069)。

要点

  • Melody瓣膜IE风险显著高于同种移植物(HR 11.89,P<0.001)。
  • Contegra管道IE风险数值升高但未达统计学显著(HR 3.20,P=0.069)。
  • 同种移植物1年IE年化发生率最低(0.40%)。

核心结论

  • 牛肺动脉管道更易发生心内膜炎,其中Melody瓣膜感染最频繁。
  • Melody瓣膜和Contegra管道IE风险均高于同种移植物,但仅Melody瓣膜达统计学显著。

研究设计与样本

  • 丹麦三级中心登记的回顾性研究,评估右心室-肺动脉管道植入后感染性心内膜炎。
  • 纳入同种移植物、Contegra管道和Melody经导管瓣膜患者,用改良Duke标准评估诊断可能性及管道受累可能性。
  • 计算植入后1年和5年IE发生率,并按Melody着陆管道亚组分析;采用含时依协变量的Cox回归建模管道类型对IE发生率的影响。

主要发现

  • 同种移植物、Contegra管道和Melody瓣膜1年IE年化发生率分别为0.40%(每100患者年0.40例)、0.97%和6.96%。
  • 同种移植物、Contegra管道和Melody瓣膜5年IE年化发生率分别为0.27%、1.12%和2.89%。
  • 以同种移植物为参照,Contegra管道IE风险HR为3.20(95%CI 0.91-11.17,P=0.069)。
  • 以同种移植物为参照,Melody瓣膜IE风险HR为11.89(95%CI 2.91-48.48,P<0.001)。

临床怎么用

  • 对植入Melody瓣膜或Contegra管道的患者应提高IE警惕并加强随访监测。
  • 同种移植物IE发生率最低,选择管道类型时可结合感染风险权衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim was to investigate the incidence of infective endocarditis (IE) in right ventricle-to-pulmonary artery conduits implanted at a Danish tertiary centre. METHODS: Cases of IE in patients with homografts, Contegra grafts and Melody transcatheter valves were evaluated retrospectively with regard to the likeliness of the diagnosis using the modified Duke criteria and the likeliness of conduit involvement. Incidence rates for IE were calculated 1 and 5 years after valve implantation for all 3 conduits, and separately for Melody subgroups depending on which conduit served as landing zone. Cox regression with time-dependent covariates was used to model the impact of the conduit type on the incidence of IE. RESULTS: Annualized incidence rates of IE in homografts, Contegra grafts and Melody valves were 0.40% (0.40 cases per 100 patient-years), 0.97% and 6.96% 1 year and 0.27%, 1.12% and 2.89% 5 years after valve implantation. Hazard ratios (HRs) were 3.20 [95% confidence interval (CI) 0.91-11.17, P = 0.069] for Contegra grafts and 11.89 (95% CI 2.91-48.48, P < 0.001) for Melody valves compared to homografts. CONCLUSIONS: Bovine pulmonary conduits were more prone to endocarditis, with Melody valves being the most frequently infected. HRs for the risk of suffering from endocarditis were substantially higher for Melody valves and Contegra grafts compared to homografts, although this finding was only statistically significant for Melody valves and not for Contegra grafts.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Gröning M, Tahri NB, Søndergaard L, et al. Infective endocarditis in right ventricular outflow tract conduits: a register-based comparison of homografts, Contegra grafts and Melody transcatheter valves. Eur J Cardiothorac Surg. 2019. PMID: 30698682. doi:10.1093/ejcts/ezy478

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。